Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management

Alan M. Polson, Steven Garrett, Norman H. Stoller, Carl L. Bandt, Philip Jerry Hanes, William J. Killoy, Charles Q. Harrold, G. Lee Southard, Susan P. Duke

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The design and conduct of a 9-month multi-center clinical trial to evaluate the safety and efficacy of subgingivally delivered 5% sanguinarium chloride (SC) and 10% doxycycline hyclate (DH) from a biodegradable drug delivery system in the treatment of adult periodontitis is described. The 3-group randomized study of 180 adults with moderate to severe periodontitis was a modified double-blind parallel design. One group received DH, one group received SC, and the other group received the vehicle control (VC). Patients selected had two quadrants with a minimum of four periodontal pockets ≤5 mm in depth with two sites ≤7 mm. All qualifying sites exhibited bleeding on gentle probing. Qualifying sites were treated at baseline and again at 4 months. Clinical response was assessed by measuring attachment level, probing depth, and bleeding on probing at monthly examinations at qualifying sites and the entire dentition. The plaque index was measured monthly to verify oral hygiene status. The parallel design afforded the opportunity to distinguish between treatment effectiveness of SC, DH, and VC independent of possible crossover effects. Also the effectiveness of oral hygiene in untreated sites of the mouth could be evaluated. Finally, treatment effects in moderate (5 to 6 mm) and deep (≤7 mm) pockets in both treated and untreated sites could be compared. The design was capable of simulating a periodontal practice maintenance program and assessing the response according to maintenance and treatment history. Study management procedures that emphasized center examiner and therapist training and adherence to protocol and procedures to reduce variability are described.

Original languageEnglish (US)
Pages (from-to)110-118
Number of pages9
JournalJournal of Periodontology
Volume68
Issue number2
DOIs
StatePublished - Jan 1 1997

Fingerprint

Doxycycline
Periodontitis
Chlorides
Oral Hygiene
Maintenance
Hemorrhage
Periodontal Pocket
Chronic Periodontitis
Dentition
Drug Delivery Systems
Mouth
Therapeutics
History
Clinical Trials
Safety
sanguinarine

Keywords

  • clinical trials
  • doxycycline/therapeutic use
  • drug delivery systems, biodegradable
  • follow-up studies
  • multi-center studies
  • periodontitis/therapy
  • sanguinarium chloride/therapeutic use

ASJC Scopus subject areas

  • Periodontics

Cite this

Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management. / Polson, Alan M.; Garrett, Steven; Stoller, Norman H.; Bandt, Carl L.; Hanes, Philip Jerry; Killoy, William J.; Harrold, Charles Q.; Southard, G. Lee; Duke, Susan P.

In: Journal of Periodontology, Vol. 68, No. 2, 01.01.1997, p. 110-118.

Research output: Contribution to journalArticle

Polson, Alan M. ; Garrett, Steven ; Stoller, Norman H. ; Bandt, Carl L. ; Hanes, Philip Jerry ; Killoy, William J. ; Harrold, Charles Q. ; Southard, G. Lee ; Duke, Susan P. / Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management. In: Journal of Periodontology. 1997 ; Vol. 68, No. 2. pp. 110-118.
@article{3804a98542e14424b85775450dc722ea,
title = "Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management",
abstract = "The design and conduct of a 9-month multi-center clinical trial to evaluate the safety and efficacy of subgingivally delivered 5{\%} sanguinarium chloride (SC) and 10{\%} doxycycline hyclate (DH) from a biodegradable drug delivery system in the treatment of adult periodontitis is described. The 3-group randomized study of 180 adults with moderate to severe periodontitis was a modified double-blind parallel design. One group received DH, one group received SC, and the other group received the vehicle control (VC). Patients selected had two quadrants with a minimum of four periodontal pockets ≤5 mm in depth with two sites ≤7 mm. All qualifying sites exhibited bleeding on gentle probing. Qualifying sites were treated at baseline and again at 4 months. Clinical response was assessed by measuring attachment level, probing depth, and bleeding on probing at monthly examinations at qualifying sites and the entire dentition. The plaque index was measured monthly to verify oral hygiene status. The parallel design afforded the opportunity to distinguish between treatment effectiveness of SC, DH, and VC independent of possible crossover effects. Also the effectiveness of oral hygiene in untreated sites of the mouth could be evaluated. Finally, treatment effects in moderate (5 to 6 mm) and deep (≤7 mm) pockets in both treated and untreated sites could be compared. The design was capable of simulating a periodontal practice maintenance program and assessing the response according to maintenance and treatment history. Study management procedures that emphasized center examiner and therapist training and adherence to protocol and procedures to reduce variability are described.",
keywords = "clinical trials, doxycycline/therapeutic use, drug delivery systems, biodegradable, follow-up studies, multi-center studies, periodontitis/therapy, sanguinarium chloride/therapeutic use",
author = "Polson, {Alan M.} and Steven Garrett and Stoller, {Norman H.} and Bandt, {Carl L.} and Hanes, {Philip Jerry} and Killoy, {William J.} and Harrold, {Charles Q.} and Southard, {G. Lee} and Duke, {Susan P.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1902/jop.1997.68.2.110",
language = "English (US)",
volume = "68",
pages = "110--118",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "2",

}

TY - JOUR

T1 - Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management

AU - Polson, Alan M.

AU - Garrett, Steven

AU - Stoller, Norman H.

AU - Bandt, Carl L.

AU - Hanes, Philip Jerry

AU - Killoy, William J.

AU - Harrold, Charles Q.

AU - Southard, G. Lee

AU - Duke, Susan P.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The design and conduct of a 9-month multi-center clinical trial to evaluate the safety and efficacy of subgingivally delivered 5% sanguinarium chloride (SC) and 10% doxycycline hyclate (DH) from a biodegradable drug delivery system in the treatment of adult periodontitis is described. The 3-group randomized study of 180 adults with moderate to severe periodontitis was a modified double-blind parallel design. One group received DH, one group received SC, and the other group received the vehicle control (VC). Patients selected had two quadrants with a minimum of four periodontal pockets ≤5 mm in depth with two sites ≤7 mm. All qualifying sites exhibited bleeding on gentle probing. Qualifying sites were treated at baseline and again at 4 months. Clinical response was assessed by measuring attachment level, probing depth, and bleeding on probing at monthly examinations at qualifying sites and the entire dentition. The plaque index was measured monthly to verify oral hygiene status. The parallel design afforded the opportunity to distinguish between treatment effectiveness of SC, DH, and VC independent of possible crossover effects. Also the effectiveness of oral hygiene in untreated sites of the mouth could be evaluated. Finally, treatment effects in moderate (5 to 6 mm) and deep (≤7 mm) pockets in both treated and untreated sites could be compared. The design was capable of simulating a periodontal practice maintenance program and assessing the response according to maintenance and treatment history. Study management procedures that emphasized center examiner and therapist training and adherence to protocol and procedures to reduce variability are described.

AB - The design and conduct of a 9-month multi-center clinical trial to evaluate the safety and efficacy of subgingivally delivered 5% sanguinarium chloride (SC) and 10% doxycycline hyclate (DH) from a biodegradable drug delivery system in the treatment of adult periodontitis is described. The 3-group randomized study of 180 adults with moderate to severe periodontitis was a modified double-blind parallel design. One group received DH, one group received SC, and the other group received the vehicle control (VC). Patients selected had two quadrants with a minimum of four periodontal pockets ≤5 mm in depth with two sites ≤7 mm. All qualifying sites exhibited bleeding on gentle probing. Qualifying sites were treated at baseline and again at 4 months. Clinical response was assessed by measuring attachment level, probing depth, and bleeding on probing at monthly examinations at qualifying sites and the entire dentition. The plaque index was measured monthly to verify oral hygiene status. The parallel design afforded the opportunity to distinguish between treatment effectiveness of SC, DH, and VC independent of possible crossover effects. Also the effectiveness of oral hygiene in untreated sites of the mouth could be evaluated. Finally, treatment effects in moderate (5 to 6 mm) and deep (≤7 mm) pockets in both treated and untreated sites could be compared. The design was capable of simulating a periodontal practice maintenance program and assessing the response according to maintenance and treatment history. Study management procedures that emphasized center examiner and therapist training and adherence to protocol and procedures to reduce variability are described.

KW - clinical trials

KW - doxycycline/therapeutic use

KW - drug delivery systems, biodegradable

KW - follow-up studies

KW - multi-center studies

KW - periodontitis/therapy

KW - sanguinarium chloride/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=0030932203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030932203&partnerID=8YFLogxK

U2 - 10.1902/jop.1997.68.2.110

DO - 10.1902/jop.1997.68.2.110

M3 - Article

C2 - 9058327

AN - SCOPUS:0030932203

VL - 68

SP - 110

EP - 118

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 2

ER -